Shares of Oracle are down after the software giant said it would purchase medical software specialist Cerner for $28.3 billion. Oracle outperformed the S&P 500 this year, but its days as a top growth stock are in the past. However, it does offer a combination of slower growth plus a dividend, for those looking to balance growth and income. #ORCL #CERN